FDA Acknowledgment Letter to Laina Callow

The FDA has posted a redacted acknowledgment letter sent to Laina Callow. This document, authored by the Center for Devices and Radiological Health (CDRH) and the Division of Management and Budget (DMB), serves as official confirmation of receipt for a submission.

While this is a routine administrative notice, regulated entities should be aware that such acknowledgments are part of the formal communication process with the FDA. Compliance officers should ensure that all necessary submissions are properly tracked and that acknowledgment letters are received and filed appropriately as part of their record-keeping obligations.